Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03516942 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion moved earlier from Dec 31, 2023 to Oct 13, 2021 Show 5 more changesShow less
    • Eligibility criteria expanded, about 9 words
    • Secondary endpoints: details revised at 8 of 8 entries
    • Study description revised
    • Site details revised at 41 of 716 sites
    • Publications: details revised at 2 of 2 entries
  2. 8 versions Re-verified since Nov 11, 2025, no change to tracked fieldsv13-v20
  3. Site details revised at 2 of 716 sitesv12
  4. Results first posted: Feb 17, 2025
    • Primary endpoint revised
    • Enrollment target: estimated 563 to confirmed 565
    • Secondary endpoints: 7 to 8
    v11
  5. Re-verified, no change to tracked fieldsv10
Show 8 earlier versionsHide 8 earlier versions
  1. Start date: May 17, 2018 to Jun 11, 2018v9
  2. Primary completion date: Sep 1, 2023 to Dec 31, 2023v8
  3. Re-verified, no change to tracked fieldsv7
  4. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 716 of 716 sites
    v6
  5. Study sites: 1 to 716v5
  6. Re-verified, no change to tracked fieldsv4
  7. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jul 25, 2018 to May 17, 2018
    v3
  8. Secondary endpoints: 5 to 7v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This research trial studies the financial burden in patients with stage I-III colon or rectal cancer who are undergoing treatment. Collecting data from patients about their cost and quality of life may help doctors to better understand the impact of cancer treatment on a patient?s employment and finances.
Trial Details
NCT Number NCT03516942
Lead Sponsor ECOG-ACRIN Cancer Research Group
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)		 Stage I Colon Cancer AJCC v8, Stage I Rectal Cancer AJCC v8, Stage II Colon Cancer AJCC v8, Stage II Rectal Cancer AJCC v8, Stage IIA Colon Cancer AJCC v8, Stage IIA Rectal Cancer AJCC v8, Stage IIB Colon Cancer AJCC v8, Stage IIB Rectal Cancer AJCC v8 +10 more
Related terms Colonic Neoplasms, Rectal Neoplasms
Enrollment 565 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov